nalidixic acid has been researched along with Sepsis in 23 studies
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
| Excerpt | Relevance | Reference |
|---|---|---|
| " coli blood isolates from patients with urosepsis for their susceptibility to nalidixic acid, ampicillin and trimethoprim-sulfamethoxazole, according to prevalence of virulence factors, phylogenetic groups and subgroups, PAI II(J96)-like domains (determined by physical linkage of cnf1, hly and hra) and PAI I(CFT073)-like domains (determined by physical linkage of papGII to the hly locus)." | 3.73 | Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates. ( Barraud, D; Bidet, P; Bingen, E; Bingen-Bidois, M; Bonacorsi, S; Houdouin, V, 2006) |
| "Erythromycin-resistance was found in only 15 strains, but while it was very low for the species C." | 1.28 | Observations made on strains of Campylobacter spp. isolated in 1989 in northern Italy. ( Gatti, M; La Placa, M; Montella, MT; Varoli, O, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (86.96) | 18.7374 |
| 1990's | 1 (4.35) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MCCABE, WR | 1 |
| BUCHBINDER, M | 1 |
| KUNIN, SS | 1 |
| SALEH, J | 1 |
| Fendukly, F | 1 |
| Karlsson, I | 1 |
| Hanson, HS | 1 |
| Kronvall, G | 1 |
| Dornbusch, K | 1 |
| Houdouin, V | 1 |
| Bonacorsi, S | 1 |
| Bidet, P | 1 |
| Bingen-Bidois, M | 1 |
| Barraud, D | 1 |
| Bingen, E | 1 |
| Nachamkin, I | 1 |
| Stowell, C | 1 |
| Skalina, D | 1 |
| Jones, AM | 1 |
| Hoop, RM | 1 |
| Smibert, RM | 1 |
| Zollikofer, H | 1 |
| Goulon, M | 3 |
| Schortgen, G | 2 |
| Tancrède, C | 2 |
| Nouailhat, F | 1 |
| Babinet, P | 1 |
| Raphaël, JC | 1 |
| Jungbluth, H | 1 |
| Tögel, H | 1 |
| Steere, AC | 1 |
| Tenney, JH | 1 |
| Mackel, DC | 1 |
| Snyder, MJ | 1 |
| Polakavetz, S | 1 |
| Dunne, ME | 1 |
| Dixon, R | 1 |
| Courtine, JC | 1 |
| Blot, P | 1 |
| Daschner, F | 1 |
| Senska-Euringer, C | 1 |
| Varoli, O | 1 |
| Gatti, M | 1 |
| Montella, MT | 1 |
| La Placa, M | 1 |
| Zinsser, HH | 1 |
| Doenecke, AL | 1 |
| Wilkowske, CJ | 1 |
| Washington, JA | 1 |
| Martin, WJ | 1 |
| Ritts, RE | 1 |
| Williams, TW | 1 |
| Sailer, JE | 1 |
| Viroslav, J | 1 |
| Knight, V | 1 |
| Glasgow, N | 1 |
| Moreland, N | 1 |
| Eichenwald, HF | 2 |
| Modde, H | 1 |
| Rapin, M | 1 |
| Barois, A | 1 |
| Bagros, P | 1 |
| Boasson, M | 1 |
| Gioannini, P | 1 |
| de Andrade, ZM | 1 |
| Zisman, M | 1 |
| de Melo, GO | 1 |
| Loureiro Júnior, L | 1 |
| Crowder, JG | 1 |
| Gilkey, GH | 1 |
| White, AC | 1 |
| McCracken, GH | 1 |
| Nelson, JD | 1 |
| Von Graevenitz, A | 1 |
| Mensch, AH | 1 |
2 reviews available for nalidixic acid and Sepsis
| Article | Year |
|---|---|
Antimicrobial therapy in children.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacitracin; Carb | 1974 |
[Pathology due to Klebsiella].
Topics: Anti-Bacterial Agents; Antigens; Bronchopneumonia; Drug Resistance, Microbial; Empyema; Enteritis; H | 1968 |
21 other studies available for nalidixic acid and Sepsis
| Article | Year |
|---|---|
BACTERIURIA AND BACTEREMIA WITH GENITOURINARY SURGERY: MODIFICATION BY ANTIMICROBIAL PROPHYLAXIS.
Topics: Anti-Infective Agents; Bacteremia; Bacteriuria; Drug Therapy; Nalidixic Acid; Naphthyridines; Postop | 1963 |
Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; | 2003 |
Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates.
Topics: Ampicillin; Anti-Infective Agents; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli In | 2006 |
Campylobacter laridis causing bacteremia in an immunosuppressed patient.
Topics: Aged; Bacteriological Techniques; Campylobacter; Campylobacter Infections; DNA, Bacterial; Drug Resi | 1984 |
[Treatment of infectious diseases in geriatrics (author's transl)].
Topics: Adrenal Cortex Hormones; Aged; Aminoglycosides; Cephalothin; Communicable Diseases; Digitalis Glycos | 1976 |
[Gram negative bacillus septicemias. Results of treatment of 31 gram negative bacillus septicemias using intravenous nalidixic acid].
Topics: Anuria; Bacteria; Drug Resistance, Microbial; Drug Synergism; Drug Tolerance; Half-Life; Humans; Inf | 1975 |
[Rifampicin in Klebsiella pneumoniae septicemia].
Topics: Adult; Carbenicillin; Drug Therapy, Combination; Humans; Klebsiella pneumoniae; Male; Nalidixic Acid | 1978 |
Pseudomonas species bacteremia caused by contaminated normal human serum albumin.
Topics: Chloramphenicol; Disease Outbreaks; Drug Resistance, Microbial; Epidemiologic Methods; Humans; Nalid | 1977 |
[Letter: Serratia marcescens septicemia treated by nalidixic acid in perfusion].
Topics: Adult; Bacterial Infections; Humans; Injections, Intravenous; Male; Nalidixic Acid; Remission, Spont | 1976 |
[Contaminated infusions as cause of nosocomial Serratia marcescens septicaemia in children (author's transl)].
Topics: Age Factors; Amikacin; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Infant, Prematur | 1975 |
Observations made on strains of Campylobacter spp. isolated in 1989 in northern Italy.
Topics: Bacterial Typing Techniques; Campylobacter; Campylobacter Infections; Campylobacter jejuni; Drug Res | 1991 |
Intravenous nalidixic acid in urogenital sepsis: report of 25 courses.
Topics: Adolescent; Adult; Aged; Chloramphenicol; Colistin; Enterobacteriaceae; Female; Humans; Injections, | 1970 |
Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalothin; Chloramphenicol; Culture Techniques; Enterobacteriac | 1970 |
Serratia marcescens as a postoperative pathogen.
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalothin; Chloramphenicol; Endocarditis, Bacter | 1971 |
[Diseases caused by Serratia marcescens (Prodigiosus)].
Topics: Bacterial Infections; Carbenicillin; Chloramphenicol; Cross Infection; Enterobacteriaceae Infections | 1972 |
[New therapeutic possibility in severe gram negative bacillus infections].
Topics: Bacteria; Bacterial Infections; Drug Evaluation; Drug Resistance, Microbial; Drug Tolerance; Humans; | 1973 |
[Serratia marcescens septicemia (apropos of 3 cases)].
Topics: Adult; Blood Transfusion; Catheterization; Gentamicins; Humans; Male; Meningitis; Nalidixic Acid; Po | 1967 |
[Use of nalidixic acid in infectious diseases of full-term and premature newborn infants].
Topics: Alanine Transaminase; Aspartate Aminotransferases; Escherichia coli; Escherichia coli Infections; Fe | 1970 |
Serratia marcescens bacteremia. Clinical observations and studies of precipitin reactions.
Topics: Adult; Aged; Amphotericin B; Ampicillin; Antibodies; Bacteriuria; Cephalothin; Chloramphenicol; Fema | 1971 |
Antimicrobial therapy in theory and practice. II. Clinical approach to antimicrobial therapy.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Juvenile; Bronchopneumonia; Chi | 1969 |
The genus aeromonas in human bacteriology; report of 30 cases and review of the literature.
Topics: Adolescent; Aeromonas; Aged; Anti-Bacterial Agents; Cellulitis; Cholestasis; Diarrhea; Drug Resistan | 1968 |